<?xml-stylesheet type="text/xsl" href="https://www.vetnurse.co.uk/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>CEVA launches Prilactone&amp;#174; to combat canine heart disease</title><link>/b/veterinary-nursing-news/posts/436</link><description> 

 Prilactone&amp;#174;, the world&amp;#39;s first aldosterone antagonist licensed for 
the treatment of canine heart disease, has been introduced by CEVA Animal 
Health. 
 Clinical trials have demonstrated that the product, which contains 
spironolactone, can</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>